Drugs Made In Stock Technical Analysis
| DMII Stock | 10.00 0.02 0.20% |
As of the 19th of February, Drugs Made shows the Coefficient Of Variation of 597.35, standard deviation of 0.142, and Mean Deviation of 0.0958. Drugs Made In technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.
Drugs Made Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Drugs, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to DrugsDrugs Made's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.Is there potential for Diversified Capital Markets market expansion? Will Drugs introduce new products? Factors like these will boost the valuation of Drugs Made. Projected growth potential of Drugs fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about Drugs Made listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Drugs Made In's market price often diverges from its book value, the accounting figure shown on Drugs's balance sheet. Smart investors calculate Drugs Made's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Since Drugs Made's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Drugs Made's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Drugs Made should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Drugs Made's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Drugs Made 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Drugs Made's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Drugs Made.
| 11/21/2025 |
| 02/19/2026 |
If you would invest 0.00 in Drugs Made on November 21, 2025 and sell it all today you would earn a total of 0.00 from holding Drugs Made In or generate 0.0% return on investment in Drugs Made over 90 days. Drugs Made is related to or competes with Inflection Point, GigCapital7 Corp, Diamond Hill, M3 Brigade, Axiom Intelligence, and Trailblazer Acquisition. Drugs Made is entity of United States. It is traded as Stock on NASDAQ exchange. More
Drugs Made Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Drugs Made's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Drugs Made In upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 0.1663 | |||
| Information Ratio | (0.16) | |||
| Maximum Drawdown | 0.9098 | |||
| Value At Risk | (0.10) | |||
| Potential Upside | 0.3036 |
Drugs Made Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Drugs Made's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Drugs Made's standard deviation. In reality, there are many statistical measures that can use Drugs Made historical prices to predict the future Drugs Made's volatility.| Risk Adjusted Performance | 0.0868 | |||
| Jensen Alpha | 0.0136 | |||
| Total Risk Alpha | 0.0072 | |||
| Sortino Ratio | (0.14) | |||
| Treynor Ratio | 3.62 |
Drugs Made February 19, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0868 | |||
| Market Risk Adjusted Performance | 3.63 | |||
| Mean Deviation | 0.0958 | |||
| Downside Deviation | 0.1663 | |||
| Coefficient Of Variation | 597.35 | |||
| Standard Deviation | 0.142 | |||
| Variance | 0.0202 | |||
| Information Ratio | (0.16) | |||
| Jensen Alpha | 0.0136 | |||
| Total Risk Alpha | 0.0072 | |||
| Sortino Ratio | (0.14) | |||
| Treynor Ratio | 3.62 | |||
| Maximum Drawdown | 0.9098 | |||
| Value At Risk | (0.10) | |||
| Potential Upside | 0.3036 | |||
| Downside Variance | 0.0276 | |||
| Semi Variance | (0.02) | |||
| Expected Short fall | (0.18) | |||
| Skewness | 0.734 | |||
| Kurtosis | 3.59 |
Drugs Made In Backtested Returns
Drugs Made is very steady at the moment. Drugs Made In secures Sharpe Ratio (or Efficiency) of 0.17, which denotes the company had a 0.17 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Drugs Made In, which you can use to evaluate the volatility of the firm. Please confirm Drugs Made's Mean Deviation of 0.0958, coefficient of variation of 597.35, and Standard Deviation of 0.142 to check if the risk estimate we provide is consistent with the expected return of 0.0233%. Drugs Made has a performance score of 13 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 0.0038, which means not very significant fluctuations relative to the market. As returns on the market increase, Drugs Made's returns are expected to increase less than the market. However, during the bear market, the loss of holding Drugs Made is expected to be smaller as well. Drugs Made In right now shows a risk of 0.14%. Please confirm Drugs Made In expected short fall, and the relationship between the value at risk and daily balance of power , to decide if Drugs Made In will be following its price patterns.
Auto-correlation | 0.52 |
Modest predictability
Drugs Made In has modest predictability. Overlapping area represents the amount of predictability between Drugs Made time series from 21st of November 2025 to 5th of January 2026 and 5th of January 2026 to 19th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Drugs Made In price movement. The serial correlation of 0.52 indicates that about 52.0% of current Drugs Made price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.52 | |
| Spearman Rank Test | 0.69 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Drugs Made technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Drugs Made In Technical Analysis
The output start index for this execution was ten with a total number of output elements of fourty-two. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Drugs Made In volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About Drugs Made Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Drugs Made In on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Drugs Made In based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Drugs Made In price pattern first instead of the macroeconomic environment surrounding Drugs Made In. By analyzing Drugs Made's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Drugs Made's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Drugs Made specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2010 | 2025 | 2026 (projected) | ROE | 1.3 | 1.17 | 1.04 | Income Quality | 1.28 | 1.15 | 1.02 |
Drugs Made February 19, 2026 Technical Indicators
Most technical analysis of Drugs help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Drugs from various momentum indicators to cycle indicators. When you analyze Drugs charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0868 | |||
| Market Risk Adjusted Performance | 3.63 | |||
| Mean Deviation | 0.0958 | |||
| Downside Deviation | 0.1663 | |||
| Coefficient Of Variation | 597.35 | |||
| Standard Deviation | 0.142 | |||
| Variance | 0.0202 | |||
| Information Ratio | (0.16) | |||
| Jensen Alpha | 0.0136 | |||
| Total Risk Alpha | 0.0072 | |||
| Sortino Ratio | (0.14) | |||
| Treynor Ratio | 3.62 | |||
| Maximum Drawdown | 0.9098 | |||
| Value At Risk | (0.10) | |||
| Potential Upside | 0.3036 | |||
| Downside Variance | 0.0276 | |||
| Semi Variance | (0.02) | |||
| Expected Short fall | (0.18) | |||
| Skewness | 0.734 | |||
| Kurtosis | 3.59 |
Drugs Made February 19, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Drugs stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.00 | ||
| Daily Balance Of Power | 1.00 | ||
| Rate Of Daily Change | 1.00 | ||
| Day Median Price | 9.99 | ||
| Day Typical Price | 9.99 | ||
| Price Action Indicator | 0.02 | ||
| Market Facilitation Index | 0.02 |
Complementary Tools for Drugs Stock analysis
When running Drugs Made's price analysis, check to measure Drugs Made's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Drugs Made is operating at the current time. Most of Drugs Made's value examination focuses on studying past and present price action to predict the probability of Drugs Made's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Drugs Made's price. Additionally, you may evaluate how the addition of Drugs Made to your portfolios can decrease your overall portfolio volatility.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities |